Category

Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS™ AUDUBON, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that the Excelsius GPS™, a revolutionary robotic guidance and navigation READ MORE

AUDUBON, PA, May 3, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016. READ MORE

AUDUBON, PA, May 3, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016. READ MORE

Globus Medical Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call AUDUBON, Pa., Feb. 07, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth qua READ MORE

Globus Medical Announces CE Mark for Excelsius GPS™ Excelsius GPS™ – Robotic Trajectory Guidance and Navigation for Surgery AUDUBON, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that the E READ MORE

AUDUBON, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Eric Ian Schwartz as its Senior Vice President and General Counsel effective April 28, 2016. READ MORE

AUDUBON, Pa., April 14, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2016 after the market close on Tuesda READ MORE

AUDUBON, PA, February 24, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the fourth quarter and year ended December 31, 2015. READ MORE

AUDUBON, PA, February 4, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and full year ended December 31, 2015 after the market close on Wednes READ MORE

AUDUBON, PA, January 6, 2016: Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2015, in advance of READ MORE